Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated October 28, 2025, reports a transaction in the company's own shares. The filing covers a share repurchase executed on October 27, 2025, as part of an existing buyback programme.
Key Financial Metrics and Transaction Details
The filing details a specific share repurchase transaction rather than providing comprehensive financial statements (revenue, profit, or cash flow). Key metrics for the transaction are as follows:
- Shares Purchased: 166,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,632.50p; highest price paid was 1,645.00p.
- Volume-Weighted Average Price (VWAP): 1,637.64p.
- Execution Venue: Trades were executed on the London Stock Exchange (XLON), CHIX, and BATE.
- Broker: BNP Paribas SA.
Material Changes and Cumulative Activity
Since the announcement of the non-discretionary agreement on September 30, 2025, GSK has purchased a total of 6,448,500 ordinary shares. Following the October 27 transaction:
- Treasury Shares Held: 253,913,344 ordinary shares.
- Shares in Issue: 4,061,507,442 ordinary shares (excluding Treasury shares).
- Voting Rights: The total number of voting rights is 4,061,507,442.
- Treasury Voting Percentage: Shares held in treasury represent 6.25% of the total voting rights.
Guidance, Outlook, and Risks
The filing does not contain new financial guidance, management commentary on operational performance, or specific risk factors beyond standard disclosures. It includes a cautionary statement noting that forward-looking statements are subject to risks and uncertainties, referencing the "Risk Factors" section in GSK's 2024 Annual Report on Form 20-F and Q2 2025 Results.
Investor Verification Checklist
- Verify the total number of shares in issue (4,061,507,442) for calculating ownership percentages under Disclosure Guidance and Transparency Rules.
- Confirm the 6.25% voting rights held in treasury to assess potential dilution or capital structure changes.
- Review the cumulative buyback volume of 6,448,500 shares since September 30, 2025, to gauge the pace of the capital return programme.
- Check the specific trading venues (XLON, CHIX, BATE) for liquidity analysis if required.